Main efficacy endpoints of the study
| All patients n (%) | ERCP+LC n (%) | ERCP n (%) | P value* | |
| Overall sample size | 114 | 46 | 68 | |
| 30-day readmission | 30 (26.3) | 1 (2.2) | 29 (42.6) | <0.001 |
| 90-day readmission | 22 (19.3) | 1 (2.2) | 21 (30.9) | <0.001 |
| Cause of readmission (biliary) | 49 (42.9) | 2 (4.3) | 47 (69.1) | 0.771 |
| 30-day mortality | 12 (10.5) | 1 (2.2) | 11 (16.2) | 0.017 |
| Cause of mortality (biliary) | 5 (4.4) | 1 (2.2) | 4 (5.9) | 0.22 |
| Length of stay in days—mean±SD | 6.95±9.45 | 5.54±2.91 | 7.90±11.95 | 0.193 |
*Student’s t-test for continuous variables and χ2 test for categorical variables.
ERCP, endoscopic retrograde cholangiopancreatography; LC, laparoscopic cholecystectomy.;